SEC 13F Intelligence

Managers / Q1 2020 · view latest →

Burren Capital Advisors Ltd

CIK 0001542952 · SUITE 851, EUROPORT, EUROPORT ROAD, GIBRALTAR, J1, GX11 1AA · (00350) 2006 8880

Reported Value
$8M
Q1 2020
Positions
3
Filings on Record
15
2019–present window
Filed
May 15, 2020
original filing

Summary

Burren Capital Advisors Ltd reported $8M in U.S.-listed holdings across 3 positions for Q1 2020.

The portfolio is heavily concentrated: Allergan alone accounts for 66.4% of reported value.

Compared with Q4 2019, the fund opened 0 new positions and exited 10.

Portfolio Metrics

Turnover
+0.2%
vs prior filed quarter
Largest Position
+66.4%
Allergan

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $16MQ1 ’19Q2 ’19: $12MQ3 ’19: $31MQ3 ’19Q4 ’19: $30MQ1 ’20: $8MQ1 ’20Q2 ’20: $418,000Q3 ’20: $133,000Q3 ’20Q1 ’21: $8MQ2 ’21: $1MQ2 ’21Q3 ’21: $0Q4 ’24: $17MQ4 ’24Q1 ’25: $28MQ2 ’25: $34MQ2 ’25Q3 ’25: $33Mfilingsflow.com

Portfolio Composition

By security type
Other: 66.4%Common Stock: 31.3%Right: 2.3%
  • Other · 66.4% · $5M
  • Common Stock · 31.3% · $3M
  • Right · 2.3% · $184,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TECH DATA CORPSOLD OUT36.3K0$5M$0
CISION LTDSOLD OUT381.1K0$4M$0
EL PASO ELEC COSOLD OUT35.6K0$2M$0
LOGMEIN INCSOLD OUT26.1K0$2M$0
INSTRUCTURE INCSOLD OUT45.9K0$2M$0
MEDICINES COSOLD OUT17.8K0$2M$0
WABCO HLDGS INCSOLD OUT8.4K0$1M$0
ZAYO GROUP HLDGS INCSOLD OUT26.8K0$929,000$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2020

3 positions
#IssuerClass% PortfolioValueShares
1ALLERGAN PLCSHS66.38%$5M30.1K
2FITBIT INCCL A31.33%$3M378.1K
3BRISTOL-MYERS SQUIBB CORIGHT 99/99/99992.29%$184,00048.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$33M16Nov 12, 202513F-HRchanges · EDGAR ↗
Q2 2025$34M15Aug 7, 202513F-HRchanges · EDGAR ↗
Q1 2025$28M16May 7, 202513F-HRchanges · EDGAR ↗
Q4 2024$17M15Feb 7, 202513F-HRchanges · EDGAR ↗
Q3 2021$01Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1M1Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$8M4May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020Under review5Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$133,0001Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$418,0001Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$8M3May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$30M13Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$31M13Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$12M4Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$16M7May 15, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.